Broadwood Partners Now Owns 33.3% of OncoCyte – 24/7 Wall St.

Broadwood Partners has disclosed a 33.3% stake in OncoCyte.

Related Keywords

,Fidelity Extended Market Index Fund ,Fund Sentiment ,Oncocyte Corp ,Chronix Biomedical Inc ,Broadwood Partners ,Price Forecast Suggests ,Asset Management ,Street Group ,Invesco Nasdaq Biotechnology ,Chronix Biomedical ,